Connect Sign In
Since 2017, ARUP Laboratories and IllumiCare have been collaborating in laboratory testing to provide real-time information about the financial impact of tests and medications ordered for a patient.
ARUP’s program of analyzing test ordering patterns, or ATOP™, helps zero in on opportunities to improve patient care for ARUP clients.
Pathologists at ARUP routinely help flesh out complex reports by phone or email and actively engage with medical practitioners, and sometimes patients.
The American Board of Internal Medicine Foundation recently released a list of its “Top 12” Choosing Wisely recommendations. It based the rankings on evidence of success.
ARUP recently rolled out their next generation UM dashboard for clients hospitals and healthcare organizations that will allow them to mine data and make it actionable.
Last week, the ECRI Institute released its top 10 list of patient safety concerns for 2018. At the top of the list for the first time ever was diagnostic error.
The Centers for Medicare & Medicaid Services published proposed Clinical Laboratory Fee Schedule. The rates outlined in the CFLS do not reflect the true cost or value of clinical lab services.
A number of studies reveal that 10–30% of laboratory tests performed in the United States are either unnecessary or inappropriate. A new report has guidelines for lab stewardship for test orders.
Confusion about lab test accuracy is not uncommon, even among medical professionals. Much of it stems from a misunderstanding of the relationship between sensitivity and specificity.
By avoiding unnecessary testing, patients and healthcare organizations can save money while still providing quality patient care.
